The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2014
DOI: 10.1007/s00005-014-0324-8
|View full text |Cite
|
Sign up to set email alerts
|

Transmission-Blocking Vaccines: Focus on Anti-Vector Vaccines against Tick-Borne Diseases

Abstract: Tick-borne diseases are a potential threat that account for significant morbidity and mortality in human population worldwide. Vaccines are not available to treat several of the tick-borne diseases. With the emergence and resurgence of several tick-borne diseases, emphasis on the development of transmission-blocking vaccines remains increasing. In this review, we provide a snap shot on some of the potential candidates for the development of anti-vector vaccines (a form of transmission-blocking vaccines) agains… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
55
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
9
1

Relationship

3
7

Authors

Journals

citations
Cited by 48 publications
(56 citation statements)
references
References 110 publications
1
55
0
Order By: Relevance
“…Potential future magic bullet solutions, capable of both ensuring that the bite of an infected tick does not result in illness and having the potential to rapidly and dramatically reduce I. scapularis -borne human infections at the population level, include (i) human vaccines or prophylactic antibody treatments against Lyme disease spirochetes or other I. scapularis -borne pathogens [104,105,109,110], and (ii) transmission-blocking anti-tick vaccines for human use with potential for simultaneous protection against multiple I. scapularis -borne pathogens [111115]. These approaches would not require daily action and vigilance, and they would be effective regardless of whether or not bites by infected ticks are noticed.…”
Section: Controlling I Scapularis and Reducing Tick-borne Diseases Imentioning
confidence: 99%
“…Potential future magic bullet solutions, capable of both ensuring that the bite of an infected tick does not result in illness and having the potential to rapidly and dramatically reduce I. scapularis -borne human infections at the population level, include (i) human vaccines or prophylactic antibody treatments against Lyme disease spirochetes or other I. scapularis -borne pathogens [104,105,109,110], and (ii) transmission-blocking anti-tick vaccines for human use with potential for simultaneous protection against multiple I. scapularis -borne pathogens [111115]. These approaches would not require daily action and vigilance, and they would be effective regardless of whether or not bites by infected ticks are noticed.…”
Section: Controlling I Scapularis and Reducing Tick-borne Diseases Imentioning
confidence: 99%
“…Besides being a critical component of the feeding process, saliva has also been shown to play a role in pathogen transmission [ 21 ]. Therefore, the identification and characterization of novel H. longicornis saliva proteins could point to candidates for the development of anti-tick and transmission-blocking vaccines [ 22 26 ] and of new pharmacological active molecules for medical application [ 18 , 20 , 27 29 ].…”
Section: Introductionmentioning
confidence: 99%
“…The roles of vector molecules and their mechanisms in transmission of arthropod-borne flaviviruses from vector to vertebrate host are not completely understood. Targeting essential vector molecules used by flaviviruses during transmission to the vertebrate host is envisioned as the best approach to develop therapeutics and vaccine candidates (3). Currently, there are no specific drugs/therapies or vaccines for several of these arthropodborne flaviviral infections (4)(5)(6).…”
mentioning
confidence: 99%